DrugPatentWatch Database Preview
Details for Patent: 6,074,670
Which drugs does patent 6,074,670 protect, and when does it expire?
This patent has eighty-five patent family members in thirty-six countries.
Summary for Patent: 6,074,670
Title: | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
Abstract: | The invention provides an immediate-release fenofibrate composition comprising (a) an inert hydrosoluble carrier covered with at least one layer containing fenofibrate in a micronized form having a size less than 20 .mu.m, a hydrophilic polymer and, optionally, a surfactant, the polymer making up at least 20% by weight of (a); and (b) optionally one or several outer phase(s) or layers(s). The invention also provides a method for preparing said composition. |
Inventor(s): | Stamm; Andre (Griesheim, FR), Seth; Pawan (Irvine, CA) |
Assignee: | Laboratoires Fournier, S.A. (Dijon, FR) |
Application Number: | 09/005,128 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; Process; |
Drugs Protected by US Patent 6,074,670
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc | TRICOR | fenofibrate | TABLET;ORAL | 021203-001 | Sep 4, 2001 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||||
Abbvie Inc | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 6,074,670
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
France | 97 00479 | Jan 17, 1997 |
Non-Orange Book US Patents Family Members for Patent 6,074,670
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
8,329,214 | Process for producing fenofibrate tablets | ➤ Sign Up |
6,596,317 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | ➤ Sign Up |
6,652,881 | Fenofibrate pharmaceutical composition having high bioavailability | ➤ Sign Up |
6,277,405 | Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it | ➤ Sign Up |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 6,074,670
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Ukraine | 61096 | ➤ Sign Up | |||
Turkey | 9901660 | ➤ Sign Up | |||
Tunisia | SN98009 | ➤ Sign Up | |||
Slovakia | 285847 | ➤ Sign Up | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |